Cancer research is not a line item. It’s a lifeline. 🔬 @ZEROcancer, @FightCRC, @LUNGevity, @PanCAN, @AACI_Cancer + @SusanGKomen join forces to urge sustained federal funding that fuels progress + saves lives. Read the special co-authored Commentary 🔗 conta.cc/3HRf2ab

We're rallying 500 climbers across the country to show that #NoOneClimbsAlone. So let's do this together. You can join from anywhere: ✔️ Stairs ✔️ Trails ✔️ Treadmills ✔️ Neighborhood walks Register for #ClimbForACure before July 1: fightcrc.org/climb

Our #ClinicalTrials Newsletter delivers the latest #colorectalcancer updates, expert insights, & clinical trial highlights straight to your inbox—explore the information that matters most to you, all in one place 📫 Thank you to our sponsors 💙: @Merck @JNJNews @bmsnews @SMMT_TX

Turn your story into action. 📣 Join our upcoming Advocacy Action Hour on July 16 at 8:30 PM ET to learn how to work with local media, write a media pitch, and amplify your advocacy beyond social media. Register now: fightcrc.org/actionhr

Don't let Congress Leave CRC Research Behind! votervoice.net/Shares/BAAAAA…

500 climbers needed nationwide by July 1. Join #climbforacure from anywhere: 💪 Free to join 💪 No travel required 💪 Climb your way 💪 Raise $250 for research Stairs. Hills. Trails. Treadmills. Your climb counts. fightcrc.org/climb

I just donated to @FightCRC ! my goal is to rally an additional $250!!! Will you join me in supporting our team! secure.qgiv.com/event/2026cl…

Tomorrow at 1 PM ET: Fight CRC's Research Highlights from @ASCO webinar. Join @ChrisCannMD of @FoxChaseCancer & @ARosen380 for a discussion of promising #clinicaltrial results, advances in precision medicine, & emerging #CRC research. Register now: fightcrc.org/webinars

New research. New possibilities. 💪 We've rounded up the most important #colorectalcancer findings from #ASCO2026 and what they could mean for patients, survivors, and caregivers. Read the recap: fightcolorectalcancer.org/as… @ASCO

For Phuong, We Keep Fighting linkedin.com/pulse/phuong-we… via @LinkedIn @FightCRC @CancerInsider

Always great to listen to @KimmieNgMD She discussed the Coming Wave of Early-Onset Cancer. With it on the rise we need to do more for these patients. A dedicated program can help with coordination of supportive care service like fertility preservation! @ASCO #ASCO26 @FightCRC

We need 500 climbers by July 1. #Climbforacure is going nationwide, and you can join from anywhere. Free to join. No travel required. Climb your way. Register today: fightcrc.org/climb

Come talk to me about patient-reported outcomes! See results of PROs in the ATOMIC A021502 trial - Atezolizumab+mFOLFOX6 vs mFOLFOX6 for adjuvant colon cancer. #ASCO26 @ALLIANCE_org

We all need to do more to incorporate structured exercise program as an affordable & available option to #CRC patients. Thank you for all your work! @CDNCancerTrials Dr. Chris Booth @GillSharlene #ASCO26 #CHALLENGE #CRCSM

So proud of @JJSingleton1 for always bravely and authentically sharing his story to ground us that the science represents real lives (people we love) 💪🏽💙💪🏽 @fightcrc @ColonCancerCoal @StupidCancer #asco26

#ASCO26 Abs LBA #3508: EPISODE-III (JCOG 1503C) randomizes ONLY stage III #coloncancer pts to ASA 100 mg x 3 yrs vs. placebo post adjuvant chemo. Primary endpoint = DFS. #cancer #cancerresearch @OncoAlert Differs vs. ALASCAA trial (Martling et al; NEJM, 2025) EPISODE-III 👉Stage III colon 👉PIK3CA MT was not required (PIK3CA MT analysis is ongoing) 👉Adjuvant therapy was required 🛑 In unselected patients, ASA 100 mg was not beneficial for DFS

Kicking off the day at @ASCO with a talk discussing the role of ctDNA across the spectrum of cancer care from early detection to treatment by Valsamo Anagnostou of @HopkinsKimmel! #ASCO26 #FightCRCRats #cancer @OncoAlert

🚨HOT TOPIC: Multicancer Early Detection: Potential Versus Proof results by Mark Robson MD @MSKCancerCenter. As an advocate do I tell patients to ask for it based on these results? Thoughts are welcome! #CRCTwitter #GITwitter #ASCO26 #FightCRCRats @ASCO @FightCRC @OncoAlert

Oh my goodness…#asco26 had amazing and brilliant @paltown1 research advocates! loved seeing you 💙 @fightcrc @manjuggm

Thank you so much to the @ColonCancerCoal for their steadfast commitment to collaboration and fighting this disease together 💙 appreciate you so much!!! @EKPPRMPLS and Chris Evans 💙 #strongertogether @fightcrc

#ASCO26: LBA #3501- Optimal duration of #adjuvant #chemotherapy (ACT) in resected stage I-IV #colorectal #cancer: Galaxy Japan #ctDNA dynamics. 👉No benefit from continuing ACT if neg 👉 Also suggests no benefit to continue > 3M if neg 👉Rise in ctDNA at 3M suggests do NOT continue 👉For my practice, the role of #ctDNA dynamics will be CONSIDERED as an additional tool during ACT. @asco @OncoAlert